Bringing important medicines and vaccines to people around the world through breakthrough science.

Novel medicines. Vaccines to help prevent disease. The work we do in our labs has helped to save and improve countless lives. Thanks to our world-class researchers, state-of-the-art technologies and unrelenting focus on scientific excellence, MSD is at the forefront of discovering and developing new ways to treat and prevent disease.

Scientific discovery and development have always been the cornerstones of our company. Today, we conduct research in a broad range of therapeutic categories – including cardiovascular disease, infectious diseases, vaccines, cancer, neurology and women’s health. And, to help achieve our goal of saving and improving lives around the world, we are expanding our capabilities in new areas, such as biologics.

Clinical Development in Belgium

MSD is performing a significant number of studies in Belgium. Overall, the regulatory environment is favorable towards clinical studies. Currently (Mid 2011) MSD is working with over 450 clinical investigators in more than 60 studies in late drug development. In addition, and as a result of partnership through supporting investigator-initiated original research and conducting development studies in Belgium, approximately 80 % of MSD First in Human studies are performed in Belgium.

Did you know?

The process of drug discovery and development is long and challenging. It begins by first exploring the roots of a disease or condition. If a compound proves promising, it then continues through years of testing and has to obtain regulatory approval before it reaches the market. A very small fraction of the compounds that commence evaluation will ultimately survive the tough process of research, development and testing to finally become medicines.